Freeman Kevin Lee 4
4 · Health Catalyst, Inc. · Filed Jun 12, 2024
Insider Transaction Report
Form 4
Freeman Kevin Lee
Chief Commercial Officer
Transactions
- Sale
Common Stock
2024-06-11$6.53/sh−7,500$49,008→ 266,153 total
Footnotes (1)
- [F1]The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 11th, 2024 in accordance with Rule 10b5-1.